These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2535430)

  • 1. Metoclopramide fails to suppress linguopharyngeal events in a rat dyskinesia model.
    Marco LA; Reed TF; Joshi RS; Aldes LD; Chronister RB
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):53-6. PubMed ID: 2535430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An electrographic characterization of ketamine-induced linguopharyngeal motor activity.
    Marco LA; Reed TF; Aldes LD; Chronister RB
    Clin Neuropharmacol; 1988 Apr; 11(2):141-50. PubMed ID: 3378223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clozapine on ketamine-induced linguopharyngeal events in rats.
    Marco LA; Joshi RS; Brigham TE; Aldes LD; Chronister RB
    Eur J Pharmacol; 1989 May; 164(1):171-3. PubMed ID: 2753078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity.
    Marco LA; Joshi RS; Brown C; Aldes LD; Chronister RB
    Psychopharmacology (Berl); 1988; 96(4):484-6. PubMed ID: 3149770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-induced tongue protrusions in rats.
    Marco LA; Pendleton R; Reed TF; Brigham TE; Aldes LD; Chronister RB
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):29-33. PubMed ID: 2576739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ketamine-induced rat model of tardive dyskinesia.
    Marco LA; Joshi RS
    Prog Neurobiol; 1992 Jun; 38(6):571-600. PubMed ID: 1350352
    [No Abstract]   [Full Text] [Related]  

  • 7. Unitary correlates of linguo-pharyngeal events in a dyskinetic rat model.
    Marco LA; Joshi RS; Cepeda NJ; Rhyne DB
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(3):413-9. PubMed ID: 1685415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoclopramide treatment of tardive dyskinesia.
    Karp JM; Perkel MS; Hersh T; McKinney AS
    JAMA; 1981 Oct 23-30; 246(17):1934-5. PubMed ID: 7288971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical control of tongue contractility in the rat under ketamine anaesthesia.
    Marco LA; Reed TF; Aldes LD; Chronister RB; Brown CB; White LE
    Clin Exp Pharmacol Physiol; 1989 May; 16(5):395-401. PubMed ID: 2766581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Parikh MD; Rathi LG; Ghandi MH; Parikh RM; Thatte S; Bharadwaj J
    J Clin Psychopharmacol; 1982 Dec; 2(6):376-9. PubMed ID: 7174860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a primate model for tardive dyskinesia.
    Bárány S; Häggström JE; Gunne LM
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):86-9. PubMed ID: 6846025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats.
    Marco LA; Joshi RS; Chronister RB
    Psychopharmacology (Berl); 1991; 103(4):462-6. PubMed ID: 1676526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine as a pharmacological model for tongue dyskinesia.
    Aldes LD; Prater SR; Chronister RB; Marco LA
    Biol Psychiatry; 1988 Jan; 23(2):159-68. PubMed ID: 3334884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monosialoganglioside on a new model of tardive dyskinesia.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Oct; 21(7):1169-79. PubMed ID: 9421829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-receptor blockade and tardive dyskinesia.
    Bateman DN; Blain PG
    Lancet; 1979 Sep; 2(8143):641. PubMed ID: 90307
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of orofacial dysfunctions on spatial and temporal dimensions of swallowing movements.
    Horn H; Kühnast K; Axmann-Krcmar D; Göz G
    J Orofac Orthop; 2004 Sep; 65(5):376-88. PubMed ID: 15378193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidopaminergic effect of metoclopramide on the rat testis and epididymis].
    Kamińska B
    Ann Acad Med Stetin; 1988; 34():69-86. PubMed ID: 2855695
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings].
    Rotrosen J; Stanley M; Lautin A; Wazer D; Gershon S
    Psychopharmacol Bull; 1981 Jan; 17(1):110-3. PubMed ID: 6262853
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dopamine in segmental intestinal ischaemia studied with dopamine receptor blockers.
    Gustafsson G
    Acta Chir Scand; 1984; 150(2):145-51. PubMed ID: 6720222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.